Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is becoming increasingly more common. Treatment for PDAC is dependent not only on stage at diagnosis, but complex anatomical relationships. Recently, the therapeutic approach to this disease has shifted from upfront surgery for technically resectable lesions t...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, Seifeldin, Alkashash, Ahmad M., Amin, Magi, Baker, Samantha J., Rose, J. Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235358/
https://www.ncbi.nlm.nih.gov/pubmed/32477933
http://dx.doi.org/10.3389/fonc.2020.00620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235358/
https://www.ncbi.nlm.nih.gov/pubmed/32477933
http://dx.doi.org/10.3389/fonc.2020.00620

Ejemplares similares